Trials / Sponsors / HuniLife Biotechnology, Inc.
HuniLife Biotechnology, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients Multiple Myeloma Refractory | Phase 1 / Phase 2 | 2025-08-18 |
| Completed | A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-08-31 |